Jamie Martin, PA
Physician Assistant · Hardy, VANPI 1013330877
Payments from drug & device makers
Across 150 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$844
- Johnson & Johnson$502
- Sanofi$413
- Lilly USA, LLC$289
- Sun Pharmaceutical Industries Inc.$277
- Amgen$142
- plus $546 from 10 others
What the payments were for
- Food & beverage$2,59886%
- Education$41614%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 51 | $844 |
| Johnson & Johnson | 17 | $502 |
| Sanofi | 21 | $413 |
| Lilly USA, LLC | 16 | $289 |
| Sun Pharmaceutical Industries Inc. | 9 | $277 |
| Amgen | 7 | $142 |
| Pfizer | 7 | $121 |
| Regeneron Healthcare Solutions, Inc. | 6 | $102 |
| Novartis | 4 | $85 |
| UCB, Inc. | 2 | $58 |
| Incyte Corporation | 3 | $58 |
| E.r. Squibb & Sons, L.L.C. | 3 | $50 |
| Organogenesis Inc. | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| ANI Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$3,014 in reported general payments places this provider in the 85th percentile of 3,376 physician assistant providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 11 | $229,848 |
| Taltz AutoinjectorIxekizumab | 35 | $226,096 |
| Dupixent PenDupilumab | 27 | $107,016 |
| Fluorouracil | 109 | $8,525 |
| Clobetasol Propionate | 106 | $4,364 |
| Doxycycline Hyclate | 108 | $1,916 |
| Tretinoin | 22 | $1,547 |
| Triamcinolone Acetonide | 194 | $1,339 |
| Ketoconazole | 107 | $1,274 |
| Metronidazole | 24 | $1,242 |
| Tacrolimus | 14 | $1,214 |
| Imiquimod | 25 | $1,188 |
| Clindamycin Phosphate | 21 | $951 |
| Betamethasone Dipropionate | 16 | $738 |
| Fluocinonide | 15 | $567 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Hardy
- John DalessandroSalem$160K
- Jalal AlghabraFredericksburg$119K
- Jamie GiovanelliVirginia Beach$118K
- John CarterStaunton$90K
- Melissa AlcoxNorfolk$73K
- Lindsay TomReston$71K
- Robert HigginsonRichmond$66K
- Jameka McElroy-BrooklynArlington$65K
- Hillary HartungNorfolk$62K
- Juliette BeristainVirginia Beach$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.